Kirk Andriano Email & Phone Number

Irving, Texas

A Fortune 500 Company: Absorbable Polymer Drug Delivery Systems

Oulu, Finland

Listed as a publicly traded company on Nordic NASDAQ Stock Exchange.

Oulu, North Ostrobothnia, Finland

Participated in BBS's IPO on the Nordic Nasdaq Stock Exchange. I made oral and video presentations in Stockholm and Helsinki supporting the IPO.

San Diego Metropolitan Area

• Served as an executive-level Research & Development Officer, directing oversight across the formation and execution of strategic business plans, including budget allocation and management, ensuring operational and.
• Led alliance management for the company with external cGMP raw material suppliers and contract research organizations.

Salt Lake City, Utah

• Executive leadership of a start-up company. Oversaw all corporate functions including fund-raising and operations.
• Led all IP, Trademark, Preclinical, Consultants and Regulatory functions which led to successful granting of Patents, Trademarks and a 510(k) clearance for a resorbable bone filler with potential for a resorbable.

Greater Boston

• Member of the senior management team responsible for all executive management of the company’s R&D functions.
• Drove alliance management for outsourced cGMP manufacturing of a proprietary variant rh-growth factor (FGF-2v) for Clinical Trials for cartilage regeneration.
• Oversaw all aspects of the company's Intellectual Property.
• Participated in the company’s venture capital fund raising of $49M in July of 2012 (the largest life science VC funding in Boston that year).

Greater Boston

• Acquired by HistogenicsManaged the company’s intellectual property and business development activities. Participated in M&A activities.
• Negotiated 2 research and feasibility agreements with ProChon’s proprietary intellectual property.

Greater Boston

• Recruited by a boutique merchant bank in Boston as CSO to drive research, development and commercialization of purchased IP assets from an ortho-biologics company.
• Led all in-licensing activities of the small molecule from Inion, Ltd., for potential accelerated and/or long-term bone growth applications, leading to a research and feasibility agreement with a leading US based.

Tampere, Finland & Cambridge, United Kingdom

• Managed R&D which included New Technologies, Biotechnology, Formulation Development, Materials Development, Product Development/Product Maintenance, Preclinical, Clinical, Regulator Affairs and Intellectual Property.
• Member of the Senior Management Team, which led a successful IPO with listing of the first Finnish company on the London Stock Exchange (The Main Board), raising a total of €55 million euros where the book was.
• Principal Investigator on 3, multi-year, multi-million-dollar grants.
• Led team in developing 15 products with regulatory approval (510k and CE-Mark) during tenure with the company.
• Strategically completed new products and modifications to existing products, adhering to strict project delivery timelines, budget constraints, and progression.

Salt Lake City, Utah

Fort Collins, Colorado

Kyoto, Japan

San Francisco Bay Area

Tampere, Pirkanmaa, Finland

Salt Lake County, Utah, United States

Doctor Of Philosophy - Phd, Bioengineering

Orthopedic Bioengineering Lab

Master Of Science - Ms, Bioengineering

Anesthesia Bioinstrumentation Lab

Bachelor Of Science - Bs, Chemistry & Biology (Double Major)